This site uses cookies. By continuing to browse the site without disabling them, you consent to our use of cookies. To learn more about the types of cookies we use, please view our cookie policy.

Indivior
  • Product Query or Adverse Event
  • Careers
  • Contact Us
  • Locations
  • International
  • About
    • History
    • Leadership
  • Diseases of Addiction
    • A Worldwide Crisis
    • The Patient Journey
  • R & D
    • Publications
    • White Papers
    • Abstracts
    • Grants
  • Products
  • Responsibility
    • Environment, Climate Change and Health and Safety
    • Communities
    • Patient Safety and Product Quality
    • Corporate Integrity Agreement
    • Integrity & Compliance
    • Business Conduct
    • People
    • Advocacy and Stakeholder Engagement
    • Transparency Program
  • Investors
  • Media
  • Investor Information
    • Annual Reports
    • Press Releases
    • RNS Filings
    • RNS Filings (Inside Information)
    • SEC Filings
    • Corporate Alert Service
    • Webcasts / Audiocasts / Presentations
    • Prospectus
    • Upcoming Events
    • Buprenorphine Market Modeling Methodology
  • Share Price
    • Share Price Center
    • Share Price Table
    • Historic Share Price
    • Share Price Calculator
    • Demerger: Base Cost
  • Corporate Governance
    • UK Corporate Governance Code
    • Leadership
    • The Board
    • Board Committees
    • Executive Committees
    • Risk Management and Internal Control
    • Indivior Integrity & Compliance Program
    • Integrity & Compliance
    • Corporate Responsibility
    • Tax Strategy
    • Global Conduct Policies
  • Shareholder Information
    • Managing Your Shareholding
    • Dividends
    • Annual General Meeting
    • American Depositary Receipts
  • Contact Us
  • Investor Information
    • Annual Reports
    • Press Releases
    • RNS Filings
    • RNS Filings (Inside Information)
    • SEC Filings
    • Corporate Alert Service
    • Webcasts / Audiocasts / Presentations
    • Prospectus
    • Upcoming Events
    • Buprenorphine Market Modeling Methodology
  • Share Price Information
    • Share Price Center
    • Share Price Table
    • Historic Share Price
    • Share Price Calculator
    • Demerger: Base Cost
  • Corporate Governance
    • UK Corporate Governance Code
    • Leadership
    • The Board
    • Board Committees
    • Executive Committees
    • Risk Management and Internal Control
    • Integrity & Compliance
    • Corporate Responsibility
    • Tax Strategy
    • Global Conduct Policies
  • Shareholder Information
    • Managing Your Shareholding
    • Dividends
    • Annual General Meeting
    • American Depositary Receipts
  • Contact Us

Webcasts / Audiocasts / Presentations

Get to know Indivior through past and current webcasts, audiocasts, and presentations.

Q1 2021 Results Webcast

Indivior FY 2020 Financial Results Presentation

Jefferies Virtual Global Healthcare Conference – November 17th – 12:00 PM US Eastern Time (ET)

Stifel Virtual Healthcare Conference – November 16th, 8:00 AM US Eastern Time (ET)

November 2020 Investor Presentation

Indivior Third Quarter and Nine Months Financial Results Presentation

Q3 Financial Results October 29th – 12:00 London Time / 8:00 AM US Eastern

Indivior First Half and Second Quarter 2020 Results Presentation

Indivior First Half and Second Quarter 2020 Financial Results on July 30th

Indivior Q1 2020 Financial Results

Next Page »
  • About
  • Diseases of Addiction
  • R & D
  • Products
  • Responsibility
  • Investors
  • Media
  • MODERN SLAVERY STATEMENT (PDF)
  • Product Query or Adverse Event
  • Careers
  • Contact
  • Terms of Use
  • Privacy Policy
  • Accessibility
  • Privacy Policy and Notice for California Residents
  • International

© 2020 Indivior PLC | INDIVIOR is a registered trademark of Indivior UK Limited.

You are now leaving Indivior.com to visit Suboxone.com a US product site intended for US residents and healthcare professionals.

Continue    Return

You are now leaving Indivior.com.

Continue    Return

You are about to leave the Indivior website

The product specific Internet site that you have requested is intended for US audiences, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or regions.

Do you wish to continue to this product-specific site?

YES
I agree
NO
I disagree